Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update.
Ma H, Qu J, Ye L, Shu Y, Qu Q.
Front Neurol. 2021 Mar 29;12:630221. doi: 10.3389/fneur.2021.630221. eCollection 2021.
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.
Hassell TJW, Charles D.
Toxins (Basel). 2020 Apr 22;12(4):269. doi: 10.3390/toxins12040269.
Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
Karp BI, Alter K.
Semin Neurol. 2016 Feb;36(1):84-91. doi: 10.1055/s-0036-1571952. Epub 2016 Feb 11.
Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
Tolosa E, Martí MJ.
Adv Neurol. 1988;49:73-84.
Genetic Update and Treatment for Dystonia.
Koptielow J, Szyłak E, Szewczyk-Roszczenko O, Roszczenko P, Kochanowicz J, Kułakowska A, Chorąży M.
Int J Mol Sci. 2024 Mar 22;25(7):3571. doi: 10.3390/ijms25073571.
Progressive thalamic nuclear atrophy in blepharospasm and blepharospasm-oromandibular dystonia.
Xu J, Luo Y, Zhang J, Zhong L, Liu H, Weng A, Yang Z, Zhang Y, Ou Z, Yan Z, Cheng Q, Fan X, Zhang X, Zhang W, Hu Q, Liang D, Peng K, Liu G.
Brain Commun. 2024 Apr 8;6(2):fcae117. doi: 10.1093/braincomms/fcae117. eCollection 2024.
Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R, Cardoso F, Truong DD.
Eur J Neurol. 2006 Feb;13 Suppl 1:21-9. doi: 10.1111/j.1468-1331.2006.01441.x.
Etiology and differential diagnosis of blepharospasm and oromandibular dystonia.
Jankovic J.
Adv Neurol. 1988;49:103-16.
Oromandibular dystonia.
Lee KH.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Oct;104(4):491-6. doi: 10.1016/j.tripleo.2007.04.001. Epub 2007 Aug 6.
Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome).
Klawans HL, Tanner CM.
Adv Neurol. 1988;49:443-50.
